Tris DBA palladium is an orally available inhibitor of GNAQ mutant uveal melanoma in vivo

Uveal melanoma is a rare but often lethal malignancy and is the leading cause of death due to an ophthalmic condition. Uveal melanoma is often diagnosed at a late stage and has a strong propensity to hepatic metastasis. Recently, the most common driver mutations in uveal melanoma have been identifie...

Descripción completa

Detalles Bibliográficos
Autores principales: Musi, Elgilda, Schwartz, Gary K., Yoo, Jae Hyuk, Odelberg, Shannon J., Li, Dean Y., Bonner, Michael Y., Selvakumar, Ponniah, Rao, Shikha, Gilbert, Linda C., Elsey, Justin, Arbiser, Jack L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6633893/
https://www.ncbi.nlm.nih.gov/pubmed/31320995
http://dx.doi.org/10.18632/oncotarget.27040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6633893/
https://www.ncbi.nlm.nih.gov/pubmed/31320995
http://dx.doi.org/10.18632/oncotarget.27040

Ejemplares similares